why choose us

First received: February 03, 2023

Clinical Trial: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A First-in-Human, Single Ascending Dose and Pharmacokinetic/Pharmacodynamic Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Intravenous Infusio

Brief Summary: The primary purpose of the study is to evaluate the safety and tolerability of single intravenous (IV) infusions of E2025 in healthy adult participants.

Read more